Hostname: page-component-745bb68f8f-b95js Total loading time: 0 Render date: 2025-02-06T06:49:14.402Z Has data issue: false hasContentIssue false

Galectins expressed differently in genetically susceptible C57BL/6 and resistant BALB/c mice during acute ocular Toxoplasma gondii infection

Published online by Cambridge University Press:  09 March 2017

S.-J. CHEN
Affiliation:
Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, Guangdong, China Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou 510080, Guangdong, China
Y.-X. ZHANG
Affiliation:
Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, Guangdong, China Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou 510080, Guangdong, China
S.-G. HUANG*
Affiliation:
School of Stomatology, Jinan University, Guangzhou 510632, Guangdong, China
F.-L. LU*
Affiliation:
Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, Guangdong, China Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou 510080, Guangdong, China
*
*Corresponding author: Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, Guangdong, China, Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou 510080, Guangdong, China and School of Stomatology, Jinan University, Guangzhou 510632, Guangdong, China. E-mail: fanglilu@yahoo.com; thshg@126.com
*Corresponding author: Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, Guangdong, China, Key Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou 510080, Guangdong, China and School of Stomatology, Jinan University, Guangzhou 510632, Guangdong, China. E-mail: fanglilu@yahoo.com; thshg@126.com

Summary

Ocular toxoplasmosis (OT) caused by Toxoplasma gondii is a major cause of infectious uveitis, however little is known about its immunopathological mechanism. Susceptible C57BL/6 (B6) and resistant BALB/c mice were intravitreally infected with 500 tachyzoites of the RH strain of T. gondii. B6 mice showed more severe ocular pathology and higher parasite loads in the eyes. The levels of galectin (Gal)-9 and its receptors (Tim-3 and CD137), interferon (IFN)-γ, IL-6 and IL-10 were significantly higher in the eyes of B6 mice than those of BALB/c mice; however, the levels of IFN-α and -β were significantly decreased in the eyes and CLNs of B6 mice but significantly increased in BALB/c mice after infection. After blockage of galectin–receptor interactions by α-lactose, neither ocular immunopathology nor parasite loads were different from those of infected BALB/c mice without α-lactose treatment. Although the expressions of Gal-9/receptor were significantly increased in B6 mice and Gal-1 and -3 were upregulated in both strains of mice upon ocular T. gondii infection, blockage of galectins did not change the ocular pathogenesis of genetic resistant BALB/c mice. However, IFN-α and -β were differently expressed in B6 and BALB/c mice, suggesting that type I IFNs may play a protective role in experimental OT.

Type
Research Article
Copyright
Copyright © Cambridge University Press 2017 

INTRODUCTION

Ocular toxoplasmosis (OT), a potential blinding disease causes a high incidence of uveitis worldwide (Holland, Reference Holland2003), which is caused by the obligate intracellular parasite Toxoplasma gondii. In spite of extensive research on epidemiology, immunology and pathophysiology of the disease (Maenz et al. Reference Maenz, Schluter, Liesenfeld, Schares, Gross and Pleyer2014), many aspects of OT still remain unclear. After T. gondii infection, nearly all mouse lineages develop a T helper (Th)1-type immune response, although they present resistant or susceptible major histocompatibility complex (MHC) haplotypes (Gazzinelli et al. Reference Gazzinelli, Hakim, Hieny, Shearer and Sher1991, Reference Gazzinelli, Xu, Hieny, Cheever and Sher1992). It has been demonstrated that C57BL/6 (B6) mice are more susceptible to the parasite than BALB/c mice (Suzuki et al. Reference Suzuki, Yang and Remington1995).

Galectins, beta-galactoside-binding animal lectins, are differentially expressed by various immune cells as well as a wide range of other cell types (Liu and Rabinovich, Reference Liu and Rabinovich2010). So far, 15 members of the galectin family have been identified in vertebrates (Viguier et al. Reference Viguier, Advedissian, Delacour, Poirier and Deshayes2014). Some galectins such as galectin (Gal)-1, -3, -8 and -9 have wide tissue distribution, whereas others such as Gal-4, -5 and -6 exhibit tissue specificity (Panjwani, Reference Panjwani2014). Galectins can regulate microbial invasion via acting as pathogen recognition receptors, and have multiple roles in both innate and adaptive immune responses (Vasta, Reference Vasta2009; Baum et al. Reference Baum, Garner, Schaefer and Lee2014). Previous study has reported that Gal-3 can significantly alter the pathogenic course of T. gondii infection (Bernardes et al. Reference Bernardes, Silva, Ruas, Mineo, Loyola, Hsu, Liu, Chammas and Roque-Barreira2006). T cell Ig and mucin domain-containing molecule-3 (Tim-3) was firstly identified as a molecule specifically expressed on interferon (IFN)-γ-producing CD4+ Th1 and CD8+ Tc1 (cytotoxic) cells in mice (Anderson et al. Reference Anderson, Anderson, Bregoli, Hastings, Kassam, Lei, Chandwaskar, Karman, Su, Hirashima, Bruce, Kane, Kuchroo and Hafler2007). Studies further demonstrated that Tim-3 is expressed on cells of both innate and adaptive immune systems, including CD4+ regulatory T cells, monocytes/macrophages, dendritic cells (DCs), and natural killer cells (Hu et al. Reference Hu, Tang, Mor and Liao2016). Gal-9 is identified as a Tim-3 ligand and Gal-9/Tim-3 interaction acts as a specific inhibitor of Th1 and Th17 immune responses (Wu et al. Reference Wu, Thalhamer, Franca, Xiao, Wang, Hotta, Zhu, Hirashima, Anderson and Kuchroo2014). Gal-9/Tim-3 interaction also plays a crucial role in immune regulation. Gal-9 administration significantly decreased viral load, inhibited mucus production and diminished lung immunopathology caused by respiratory syncytial virus infections (Lu et al. Reference Lu, McCoy, Xu, Hu, Chen, Jiang, Han, Chen and Wang2015). Studies demonstrated that Gal-9 also binds to CD44 (Chiba et al. Reference Chiba, Baghdadi, Akiba, Yoshiyama, Kinoshita, Dosaka-Akita, Fujioka, Ohba, Gorman, Colgan, Hirashima, Uede, Takaoka, Yagita and Jinushi2012), CD137 (Liang and Qin, Reference Liang and Qin2013) and protein disulphide isomerase (PDI) (Kojima et al. Reference Kojima, Arikawa, Saita, Goto, Tsumura, Tanaka, Masunaga, Niki, Oomizu and Hirashima2011). CD44 is a transmembrane adhesion molecule that is present on a wide variety of cell types, including leucocytes and parenchymal cells, and is an important player in leucocyte trafficking (Sunil et al. Reference Sunil, Francis, Vayas, Cervelli, Choi, Laskin and Laskin2015). CD137 is a co-stimulatory member of the tumour necrosis factor (TNF) receptor family discovered on T cells undergoing activation (Kwon and Weissman, Reference Kwon and Weissman1989).

So far, the immunopathological mechanisms that lead to ocular toxoplasmic infection remain largely unknown. Currently, it is not clear what role of galectins play in OT and whether manipulating galectin binding to their receptors can influence the magnitude and effectiveness of T. gondii immunity, their expression patterns in the context of OT have thus far not been elucidated. In addition, the pathway involved in the induction of IFN-I by the interaction of Gal-9 and its receptors in ocular immunopathogenesis during T. gondii infection have not been reported. In this study, we seek to compare the expression levels of Gal-1, -3, -8, -9, the receptors of Gal-9 (Tim-3, CD44, CD137 and PDI), IFN-I (IFN-α and -β), IFN-II (IFN-γ) and IL-10 in the eyes between T. gondii-susceptible B6 and -resistant BALB/c mice after ocular T. gondii infection, and the roles of galectins in BALB/c mice during ocular T. gondii infection were investigated with the blockage of galectins by α-lactose in vivo. We demonstrated that the signalling of Gal-9 and its receptors (Tim-3 and CD137) may involve in the development of OT in ocular T. gondii-infected B6 mouse model, and IFN-I production may play a protective role during ocular T. gondii infection.

MATERIALS AND METHODS

Mice, parasite, intravitreal infection and treatment with α-lactose

B6 and BALB/c mice, female, aged 5–6 weeks were obtained from the Experiment Animal Center of Sun Yat-sen University (Guangzhou, China). All animals were maintained in specific-pathogen-free environment and had free access to a commercial basal diet and tap water ad libitum. Tachyzoites of T. gondii RH strain stored in our laboratory were propagated by intraperitoneal passage in Kunming mice at 4–5-day intervals. For intravitreal infection, according to Charles et al. (Reference Charles, Callegan and Blader2007) and modified, 1-μL parasite suspension containing 500 tachyzoits or the same volume of phosphate-buffered saline (PBS) was injected into one of the eye of per mice using a 10-μL Hamilton microsyringe. Some mice were injected intraperitoneally (i.p.) with 150 mm of α-lactose solution in PBS twice daily starting from 1 day post-infection (dpi) until the day mice were sacrificed. Animals were sacrificed at 12 h after the last treatment and their eyes and cervical lymph nodes (CLNs) were taken for further analysis (Sehrawat et al. Reference Sehrawat, Reddy, Rajasagi, Suryawanshi, Hirashima and Rouse2010). A total of 30 mice of each strain were used in the experiments: eight mice were intravitreally injected with 500 T. gondii tachyzoites, eight mice were intravitreally injected with 500 T. gondii tachyzoites and treated with α-lactose; seven mice were injected i.p. with α-lactose alone; and seven mice were intravitreally injected with equal volume of PBS as negative controls. Mice infected with T. gondii were sacrificed by CO2 asphyxiation for examination at 8 dpi. All experiments were performed in compliance with the requirements of the Animal Ethics Committee at Sun Yat-sen University.

Histopathological analysis

Mice were sacrificed by CO2 asphyxiation at 8 dpi, and the eyes were harvested and immediately fixed in 10% buffered natural formaldehyde (Guangzhou Chemical Reagent Factory, China) for 48 h. Five-micrometre-thick sections of the organs from each mouse, stained with haematoxylin and eosin (H&E) (Sigma-Aldrich), were evaluated for histological changes and parasite proliferations.

Measurement of mRNA expression using quantitative real-time reverse transcription-polymerase chain reaction (qRT–PCR)

Total RNA was extracted from the eye and CLN samples of each mouse using RNA Extraction kit (TaKaRa Bio, Inc., Tokyo, Japan) according to the manufacturer's protocol. The quality of total RNA was analysed by running 5 µL of each RNA sample on a 1·0% agarose gel stained with ethidium bromide. The quantity of total RNA was estimated by measuring the ratio of absorbance at 260 and 280 nm using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, DE, USA). First-strand cDNA was constructed from 1·0 µg of total RNA with oligo (dT) as primers using a PrimeScript 1st Strand cDNA Synthesis Kit (TaKaRa Bio, Inc.) following the manufacturer's protocol. cDNA was stored at −80 °C until use. To determine tissue mRNA levels of Gal-1, -3, -8 and -9, Tim-3, CD44, CD137, PDI, IFN-α, IFN-β, IFN-γ and IL-10, qRT–PCR was performed using SYBR Green QPCR Master Mix (TaKaRa Bio, Inc.) according to the manufacturer's instructions. For eye parasite loads, the levels of mRNA transcripts of T. gondii tachyzoite surface antigen 1 (SAG1) gene were measured by using qRT–PCR. Primers for the qRT–PCR are listed in Table 1. Briefly, a total of 10 µL reaction mixture contained 5·0 µL of SYBR® Premix Ex TaqTM (2×), 0·5 µL of each primer (10 pm), 3·0 µL of dH2O and 1·0 µL of cDNA (0·2 µµL−1). Amplification was pre-denaturized for 30 s at 95 °C followed by 43 cycles of 5 s at 95 °C and 20 s at 60 °C with a LightCycler® 480 instrument (Roche Diagnostics, AL, USA). Values are means from triplicate measurements, specific mRNA expression levels were normalized to that of the housekeeping gene, β-actin and the results are expressed as fold change compared with uninfected controls.

Table 1. Primer sequences of mouse target cytokines and housekeeping genes used for quantitative real-time polymerase chain reaction (qRT–PCR) assays

Statistical analysis

Results of experimental studies were reported as mean ± s.d. Independent-sample t-test and one way ANOVA followed by LSD post hoc test were performed to determine the statistical significance of differences between samples by using SPSS software for windows (version 19·0; SPSS, Inc., IL, USA). All graphs were performed using GraphPad Prism software and a value of P < 0·05 was considered statistically significant.

RESULTS

B6 mice displayed significantly severer ocular pathology and higher ocular parasite loads than those in BALB/c mice

Compared with BALB/c mice, B6 mice developed severe ocular pathology characterized by an intense inflammatory response and severe necrosis as described previously, while BALB/c mice showed moderate inflammatory response and necrosis (Fig. 1A). To compare the parasite loads in the two strains of mice, the mRNA levels of T. gondii SAG1 were determined in the eyes. As expected, B6 mice showed a significantly higher parasite loads than those of BALB/c mice in the eyes and CLNs at 8 dpi (P < 0·001) (Fig. 1B).

Fig. 1. Histological changes (A) and the mRNA expressions of SAG1 (B) in the eyes of T. gondii-infected B6 and BALB/c mice at 8 dpi. Naive mice, no histological alterations were observed; B6 mice-infected with T. gondii at 8 dpi showed severe damage in the eye; BALB/c mice showed moderate damage in the eye. Original magnification for eyes × 40, H&E stain. The mRNA expressions of SAG1 in the eye tissues of T. gondii-infected mice were measured by using qRT–PCR. Values are means from triplicate measurements, and data are presented as means ± s.d. The statistical analysis was performed by independent-sample t-test; ***P < 0·001, T. gondii-infected B6 mice vs T. gondii-infected BALB/c mice. There were four mice per group, and data are representative of those from two experiments.

B6 mice displayed significantly higher mRNA expressions of Gal-1, -3, -8 and -9 and the receptors of Gal-9 (Tim-3 and CD137) in the eyes and CLNs than those in BALB/c mice

To determine the expression of galectins supposed to be involved in acute experimental OT, our results showed that compared with uninfected control mice, there were significantly increased mRNA expression levels of Gal-1 (P < 0·05), -3 (P < 0·01), -8 (P < 0·05) and -9 (P < 0·01) in the eyes of T. gondii-infected B6 mice at 8 dpi; significantly increased Gal-8 (P < 0·05) in the CLNs of of B6 mice and significantly increased Gal-1 and -3 in the CLNs (P < 0·001) of both B6 and BALB/c mice (Fig. 2A). As shown in Fig. 2B, Tim-3 levels were significantly increased in the eyes (P < 0·01) and CLNs (P < 0·01) of both B6 and BALB/c mice. CD137 levels were also significantly increased in the eyes and CLNs of both B6 (P < 0·001) and BALB/c (P < 0·01) mice. However, compared with BALB/c mice, there were significantly increased Gal-1 (P < 0·05), -3 (P < 0·01) and -9 (P < 0·01) in the eyes and significantly increased Tim-3 (P < 0·05) and CD137 (P < 0·001 and P < 0·05, respectively) in both the eyes and CLNs of B6 mice. These results indicate that ocular T. gondii infection leads to the induction of expressions of Gal-9 and its receptors (Tim-3 and CD137) in susceptible B6 mice, and the induction of Gal-1 or -3 in both susceptible B6 and resistant BALB/c mice.

Fig. 2. The mRNA expressions of Gal-1, -3, -8 and -9 (A) and the receptors for Gal-9 (Tim-3, CD137, CD44 and PDI) (B) in the eyes and CLNs of T. gondii-infected mice at 8 dpi by using qRT–PCR. Values are means from triplicate measurements, and data are presented as means ± s.d. The statistical analysis was performed by independent-sample t-test; * P < 0·05, **P < 0·01, ***P < 0·001 vs control group; #P < 0·05, ###P < 0·001, T. gondii-infected B6 mice vs T. gondii-infected BALB/c mice. There were four mice per group, and data are the representative of those from two experiments.

BALB/c mice displayed significantly higher expressions of IFN-I (IFN-α and -β) in the eyes and CLNs than those in B6 mice

To assess the differences in cytokine production between the two strains of mice after ocular infection with T. gondii, the mRNA expressions of IFN-I (IFN-α and -β), IFN-II (IFN-γ), IL-10 and IL-6 in the eyes and CLNs were determined by using qRT–PCR. As shown in Fig. 3A, compared with uninfected control mice, there were significantly deceased IFN-α and -β in both the eyes (P < 0·05) and CLNs (P < 0·05) of B6 mice, but significantly increased IFN-α and -β in both the eyes (P < 0·05) and CLNs (P < 0·05) of BALB/c mice at 8 dpi; there were significant increased IFN-γ in the eyes (P < 0·001) of both B6 and BALB/c mice, and in the CLNs (P < 0·001) of B6 mice at 8 dpi. As shown in Fig. 3B, compared with uninfected control mice, there were significantly increased IL-6 and -10 in both the eyes (P < 0·001) and CLNs (P < 0·01) of B6 mice, and significantly increased IL-10 in the CLNs (P < 0·05) of BALB/c mice at 8 dpi.

Fig. 3. The mRNA expressions of IFN-α, IFN-β, IFN-γ, IL-6 and IL-10 in the eyes and CLNs of T. gondii-infected mice at 8 dpi by using qRT–PCR. (A) IFN-α, IFN-β and IFN-γ; (B) IL-6 and IL-10. Values are means from triplicate measurements, and data are presented as means ± s.d. The statistical analysis was performed by independent-sample t-test; *P < 0·05, **P < 0·01, ***P < 0·001 vs control group; #P < 0·05, ###P < 0·001, T. gondii-infected B6 mice vs T. gondii-infected BALB/c mice. There were four mice per group, and data are representative of those from two experiments.

Ocular immunopathology in BALB/c mice was independent of galectins

To study the role of galectins in resistant BALB/c mice against ocular infection with T. gondii, BALB/c mice were intravitreally infected with T. gondii. As shown in Fig. 4, moderate inflammation and necrosis, and obvious tachyzoites or pseudocysts were observed in the eye tissues of BALB/c mice with or without α-lactose treatment. No significant differences of parasite loads in the eyes and CLNs were detected between the two groups.

Fig. 4. Histological changes in the eyes (A) and SAG1 mRNA expressions in the eye and CLN tissues (B) of T. gondii-infected BALB/c mice with or without α-lactose treatment. Moderate histopathological changes were observed in the eyes of T. gondii-infected BALB/c mice with or without α-lactose treatment at 8 dpi. Tachyzoites or pseudocysts were indicated with arrows; their enlarged images were shown in small windows. Original magnification for eyes tissues × 1000. H&E stain. The SAG1 mRNA expressions in the eyes and CLNs were measured by using qRT–PCR. Values are means from triplicate measurements, and data are presented as means ± s.d. The statistical analysis was performed by independent-sample t-test. There were four mice per group, and data are representative of those from two experiments.

Furthermore, the cytokine expressions were measured in BALB/c mice with or without α-lactose treatment. As shown in Fig. 5, compared with uninfected controls, the levels of IFN-α, -β and -γ in the eyes of T. gondii-infected BALB/c mice either with α-lactose treatment (P < 0·05, <0·05 and <0·001, respectively) or without α-lactose treatment (P < 0·05, <0·05 and <0·001, respectively) were significantly increased after ocular T. gondii infection; however, the expressions of IFN-α, -β and -γ had no significant differences between these two groups (Fig. 5A). Similarly, the levels of IL-6 and -10 in the eyes of T. gondii-infected BALB/c mice either with α-lactose treatment (P < 0·01 and <0·05, respectively) or without α-lactose treatment (P < 0·01 and <0·05, respectively) were significantly increased after ocular T. gondii infection but had no significant differences between these two groups (Fig. 5B). Because both ocular pathology and parasite loads showed no differences between T. gondii-infected BALB/c mice with or without α-lactose treatment, which suggests that galectins did not play an essential role for ocular immunopathology in genetic resistant BALB/c mice. In contrast, the severity of ocular pathology in susceptible B6 mice may be related to the expressions of galectins.

Fig. 5. The mRNA expressions of IFN-α, IFN-β, IFN-γ, IL-6 and IL-10 in the eyes and CLNs of T. gondii-infected BALB/c mice with or without α-lactose treatment at 8 dpi by using qRT–PCR. (A) IFN-α, IFN-β and IFN-γ; (B) IL-6 and IL-10. Values are means from triplicate measurements, and data are presented as means ± s.d. The statistical analysis was performed by one-way ANOVA with LSD's post hoc test; *P < 0·05, ***P < 0·001 vs control group, #P < 0·05, ##P < 0·01, ###P < 0·001 vs α-lactose-control group. There were four mice per group, and data are representative of those from two experiments.

DISCUSSION

Toxoplasma gondii infection is the most common cause of posterior uveitis worldwide (Holland, Reference Holland2004). At present, laboratory mice continue to be the experimental model of choice for the investigation of most aspects of OT (Dukaczewska et al. Reference Dukaczewska, Tedesco and Liesenfeld2015). Using eye inoculation by injecting 100 RH tachyzoites into the anterior chamber of eyes, our previous work demonstrated that genetic factors of the host as well as the parasite strain are critical in determining susceptibility to experimental OT in murine models (Lu et al. Reference Lu, Huang, Hu and Kasper2005). In this study, we investigated the role of galectins in the regulation of immune responses against ocular infection with T. gondii in susceptible B6 and resistant BALB/c mice by intravitreal injection of 500 RH tachyzoits. We firstly determined the expressions of Gal-1, -3, -8, -9 and its receptors (Tim-3, CD44, CD137 and DPI), IFN-α, IFN-β, IFN-γ, IL-6 and IL-10 in naive and T. gondii-infected B6 and BALB/c mice. Finally, blockage of galectins by treatment with α-lactose on the BALB/c background mice was used to investigate the role of galectins against ocular immunopathology. Taken together, our data indicate that acute ocular T. gondii infection results in increased Gal-1 and -3, especially Gal-9/Tim-3 and Gal-9/CD137 mRNA expressions in the eyes of susceptible B6 mice; however, the blockage of galectins did not change the severity of ocular toxoplasmic immunopathology and parasite loads in BALB/c mice. In addition, IFN-I may play a protective role in experimental OT but their expressions may be under genetic control.

In the current study, intraocular infection with tachyzoites of T. gondii induces elevated levels of IFN-γ that lead to the development of ocular immunopathology in both genetically susceptible B6 and resistant BALB/c mice; however, T. gondii-infected BALB/c mice developed lighter immunopathology. It has been reported that differentially expressed molecules in susceptible mice versus resistant mice are key to the development of immunopathology of T. gondii infection (Liesenfeld et al. Reference Liesenfeld, Kosek, Remington and Suzuki1996; Buzoni–Gatel et al. Reference Buzoni–Gatel, Debbabi, Mennechet, Martin, Lepage, Schwartzman and Kasper2001; Liesenfeld, Reference Liesenfeld2002). T. gondii infection elicits a strong Th1 response including with IFN-γ release (Suzuki et al. Reference Suzuki, Orellana, Schreiber and Remington1988). IFN-γ is required for an efficient activation of macrophages, and macrophages are of critical importance in antitoxoplasmic activity (Deckert-Schlüter et al. Reference Deckert-Schlüter, Rang, Weiner, Huang, Wiestler, Hof and Schlüter1996). There is a remarkable difference in susceptibility to peroral infection with T. gondii among inbred strains of mice. IFN-γ mediates necrosis in the ilea of B6 mice after the ME49 strain of T. gondii infection, whereas the same cytokine plays a critical role in the resistance of genetically resistant BALB/c mice (Liesenfeld et al. Reference Liesenfeld, Kosek, Remington and Suzuki1996). Here we observed significantly higher levels of IFN-γ, IL-6 and IL-10 in the eyes and CLNs of B6 compared with BALB/c mice after ocular T. gondii infection. Following intraocular reinfection with the avirulent PRU strain of T. gondii, strongly enhanced production of IL-6 and IFN-γ in the aqueous humour of eyes was measured in B6 mice (Rochet et al. Reference Rochet, Brunet, Sabou, Marcellin, Bourcier, Candolfi and Pfaff2015). We previously reported that BALB/c mice when rendered deficient in IL-10 develop severe ocular immunopathology upon T. gondii infection via ocular inoculation (Lu et al. Reference Lu, Huang and Kasper2003), here we further demonstrated the key role of IL-10 in preventing the development of ocular immunopathology.

We found increased levels of Gal-1, -3, -8, -9, Tim-3 and CD137 in the eyes and Gal-8 in the CLNs of B6 mice; in addition, increased Gal-1 and -3, Tim-3 and CD137 were detected in the CLNs of both strains of mice after infection. After ocular Pseudomonas aeruginosa infection, subconjunctival injection of recombinant Gal-1 can significantly diminish corneal lesion severity through regulation of corneal infiltration of neutrophils and T cells, and modulation of Th17 and regulatory T (Treg) cell responses in the cornea as well as local draining lymph nodes (Suryawanshi et al. Reference Suryawanshi, Cao, Thitiprasert, Zaidi and Panjwani2013). In corneal epithelium, an association of Gal-3 with cell surface mucins contributes to maintenance of the ocular surface epithelial barrier function (Argüeso et al. Reference Argüeso, Guzman-Aranguez, Mantelli, Cao, Ricciuto and Panjwani2009). Gal-8 can promote the differentiation of Treg and Th2 cells by modulating IL-2 and TGFβ signalling (Sampson et al. Reference Sampson, Suryawanshi, Chen, Rabinovich and Panjwani2016). Gal-8 attenuates the retinal pathology in a murine model of experimental autoimmune uveitis through enhancing the Treg cell response and inhibiting inflammation of the retina (Sampson et al. Reference Sampson, Hasegawa, Mulki, Suryawanshi, Jiang, Chen, Rabinovich, Connor and Panjwani2015). Tim-3/Gal-9 interaction plays a critical role at influencing the expression of herpes simplex virus induced ocular lesions (Sehrawat et al. Reference Sehrawat, Suryawanshi, Hirashima and Rouse2009). Similarly, our data in this study indicated that Gal-9/Tim-3 and/or Gal-9/CD137 interaction may play a role in OT of B6 mice. However, after ocular T. gondii infection, no differences in ocular immunopathology or parasite loads were detected in BALB/c mice with α-lactose treatment compared to those without α-lactose treatment. Therefore, our data suggest that Gal-1, -3, -8 and -9 and its receptors were not key players in preventing ocular immunopathology induced by T. gondii in resistant BALB/c mice.

We found significantly higher IFN-α/β expressions in T. gondii-infected BALB/c mice but significantly lower IFN-α/β expressions in infected B6 mice. IFN-I signalling through the IFN-α/β receptor (Ifnar) is critically important for innate immune defence (Sadler and Williams, Reference Sadler and Williams2008). A pivotal effect of Ifnar/IFN-β signalling in retinal microglia and macrophages that reduce chronic inflammation and pathological angiogenesis in age-related macular degeneration and thereby limit the development of choroidal neovascularization lesions (Lückoff et al. Reference Lückoff, Caramoy, Scholz, Prinz, Kalinke and Langmann2016). It has been reported that T. gondii is capable of eliciting IFN-α/β production in the serum of infected mice (Freshman et al. Reference Freshman, Merigan, Remington and Brownlee1966). IFN-α/β production is an important factor associated with acute toxoplasmosis-induced immunosuppression in NMR1 mice (Swiss-type mice) infected with the RH strain of T. gondii (Diez et al. Reference Diez, Galdeano, Nicolas and Cisterna1989). Using retinal pigment epithelial cell in vitro model system to evaluate T. gondii replication and the regulation of this replication by cytokines, it demonstrated that pretreatment of cultures with recombinant human IFN-α, -β or -γ prior to inoculation inhibited T. gondii replication in a dose-dependent manner, by the induction of indoleamine 2,3-dioxygenase (Nagineni et al. Reference Nagineni, Pardhasaradhi, Martins, Detrick and Hooks1996). In vivo study showed that recombinant murine IFN-β protected mice against a lethal infection of T. gondii (Orellana et al. Reference Orellana, Suzuki, Araujo and Remington1991). Inflammatory monocytes are major producers of IFN-β in mesenteric lymph nodes following oral infection of type II Prugniaud parasites in B6 mice, and mice lacking the receptor for IFN-1 (Toll-like receptors) show higher parasite loads and reduced survival (Han et al. Reference Han, Melichar, Coombes, Chan, Koshy, Boothroyd, Barton and Robey2014). Our data suggest that increased IFN-α/β levels in resistant BALB/c mice may facilitate the inhibition of T. gondii replication in this model.

In conclusion, the finding that B6 mice expressed higher levels of Gal-9 and its receptors (Tim-3 and CD137) than those in BALB/c mice after ocular T. gondii infection demonstrates that the expressions of Gal-9 and its receptors are genetically regulated in mice. However, blockage of galectin by α-lactose is not sufficient to change the ocular immunopathology in genetic resistant BALB/c mice. Deeper understanding of the role of galectins in T. gondii infection will shed new light on exploring the pathogenesis of OT. In addition, whether the markedly different expressions of IFN-α/β between intraocularly T. gondii-infected B6 and BALB/c mice are one of the mechanisms that they are genetically susceptible or resistant to the parasite needs to be further investigated.

FINANCIAL SUPPORT

This work was supported in part by grants from the Natural Science Foundation of China (no. 81471973) and the Science and Technology Planning Project of Guangdong Province, China (nos. 2014A020212108, 2013B021800043 and 2014A020212212).

CONFLICT OF INTEREST

None.

References

REFERENCES

Anderson, A. C., Anderson, D. E., Bregoli, L., Hastings, W. D., Kassam, N., Lei, C., Chandwaskar, R., Karman, J., Su, E. W., Hirashima, M., Bruce, J. N., Kane, L. P., Kuchroo, V. K. and Hafler, D. A. (2007). Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318, 11411143.CrossRefGoogle ScholarPubMed
Argüeso, P., Guzman-Aranguez, A., Mantelli, F., Cao, Z., Ricciuto, J. and Panjwani, N. (2009). Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier. Journal of Biological Chemistry 284, 2303723045.CrossRefGoogle Scholar
Baum, L. G., Garner, O. B., Schaefer, K. and Lee, B. (2014). Microbe-host interactions are positively and negatively regulated by galectin-glycan interactions. Frontiers in Immunology 5, 284.CrossRefGoogle ScholarPubMed
Bernardes, E. S., Silva, N. M., Ruas, L. P., Mineo, J. R., Loyola, A. M., Hsu, D. K., Liu, F. T., Chammas, R. and Roque-Barreira, M. C. (2006). Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity. American Journal of Pathology 168, 19101920.CrossRefGoogle ScholarPubMed
Buzoni–Gatel, D., Debbabi, H., Mennechet, F. J., Martin, V., Lepage, A. C., Schwartzman, J. D. and Kasper, L. H. (2001). Murine ileitis after intracellular parasite infection is controlled by TGF-β–producing intraepithelial lymphocytes. Gastroenterology 120, 914924.CrossRefGoogle ScholarPubMed
Charles, E., Callegan, M. C. and Blader, I. J. (2007). The SAG1 Toxoplasma gondii surface protein is not required for acute ocular toxoplasmosis in mice. Infection and Immunity 75, 20792083.CrossRefGoogle Scholar
Chiba, S., Baghdadi, M., Akiba, H., Yoshiyama, H., Kinoshita, I., Dosaka-Akita, H., Fujioka, Y., Ohba, Y., Gorman, J. V., Colgan, J. D., Hirashima, M., Uede, T., Takaoka, A., Yagita, H. and Jinushi, M. (2012). Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nature Immunology 13, 832842.CrossRefGoogle ScholarPubMed
Deckert-Schlüter, M., Rang, A., Weiner, D., Huang, S., Wiestler, O. D., Hof, H. and Schlüter, D. (1996). Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation. Laboratory Investigation: a Journal of Technical Methods and Pathology 75, 827841.Google ScholarPubMed
Diez, B., Galdeano, A., Nicolas, R. and Cisterna, R. (1989). Relationship between the production of interferon-α/β and interferon-γ during acute toxoplasmosis. Parasitology 99, 1115.CrossRefGoogle ScholarPubMed
Dukaczewska, A., Tedesco, R. and Liesenfeld, O. (2015). Experimental Models of Ocular Infection with Toxoplasma Gondii . European Journal of Microbiology & Immunology (Bp) 5, 293305.CrossRefGoogle ScholarPubMed
Freshman, M. M., Merigan, T. C., Remington, J. S. and Brownlee, I. E. (1966). In vitro and in vivo antiviral action of an interferon-like substance induced by Toxoplasma gondii . Proceedings of the Society for Experimental Biology and Medicine 123, 862866.CrossRefGoogle ScholarPubMed
Gazzinelli, R. T., Hakim, F. T., Hieny, S., Shearer, G. M. and Sher, A. (1991). Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. Journal of Immunology 146, 286292.CrossRefGoogle ScholarPubMed
Gazzinelli, R., Xu, Y., Hieny, S., Cheever, A. and Sher, A. (1992). Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii . The Journal of Immunology 149, 175180.CrossRefGoogle ScholarPubMed
Han, S. J., Melichar, H. J., Coombes, J. L., Chan, S. W., Koshy, A. A., Boothroyd, J. C., Barton, G. M. and Robey, E. A. (2014). Internalization and TLR-dependent type I interferon production by monocytes in response to Toxoplasma gondii . Immunology and Cell Biology 92, 872881.CrossRefGoogle ScholarPubMed
Holland, G. N. (2003). Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. American Journal of Ophthalmology 136, 973988.CrossRefGoogle ScholarPubMed
Holland, G. N. (2004). Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. American Journal of Ophthalmology 137, 117.Google Scholar
Hu, X. H, Tang, M. X., Mor, G. and Liao, A. H. (2016). Tim-3: expression on immune cells and roles at the maternal-fetal interface. Journal of Reproductive Immunology 118, 9299.CrossRefGoogle ScholarPubMed
Kojima, K., Arikawa, T., Saita, N., Goto, E., Tsumura, S., Tanaka, R., Masunaga, A., Niki, T., Oomizu, S. and Hirashima, M. (2011). Galectin-9 attenuates acute lung injury by expanding CD14–plasmacytoid dendritic cell-like macrophages. American Journal of Respiratory and Critical Care Medicine 184, 328339.CrossRefGoogle ScholarPubMed
Kwon, B. S. and Weissman, S. M. (1989). cDNA sequences of two inducible T-cell genes. Proceedings of the National Academy of Sciences of the United States of America 86, 19631967.CrossRefGoogle ScholarPubMed
Liang, S. and Qin, X. (2013). Critical role of type I interferon-induced macrophage necroptosis during infection with Salmonella enterica serovar Typhimurium. Cellular & Molecular Immunology 10, 99100.CrossRefGoogle ScholarPubMed
Liesenfeld, O. (2002). Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? Journal of Infectious Diseases 185 (Suppl. 1), S96101.CrossRefGoogle ScholarPubMed
Liesenfeld, O., Kosek, J., Remington, J. S. and Suzuki, Y. (1996). Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii . Journal of Experimental Medicine 184, 597607.CrossRefGoogle ScholarPubMed
Liu, F. T. and Rabinovich, G. A. (2010). Galectins: regulators of acute and chronic inflammation. Annals of the New York Academy of Sciences 1183, 158182.CrossRefGoogle ScholarPubMed
Lu, F., Huang, S. and Kasper, L. H. (2003). Interleukin-10 and pathogenesis of murine ocular toxoplasmosis. Infection and Immunity 71, 71597163.CrossRefGoogle ScholarPubMed
Lu, F., Huang, S., Hu, M. S. and Kasper, L. H. (2005). Experimental ocular toxoplasmosis in genetically susceptible and resistant mice. Infection and Immunity 73, 51605165.CrossRefGoogle ScholarPubMed
Lu, X. X., McCoy, K. S., Xu, J. L., Hu, W. K., Chen, H. B., Jiang, K., Han, F., Chen, P. and Wang, Y. L. (2015). Galectin-9 ameliorates respiratory syncytial virus-induced pulmonary immunopathology through regulating the balance between Th17 and regulatory T cells. Virus Research 195, 162171.CrossRefGoogle ScholarPubMed
Lückoff, A., Caramoy, A., Scholz, R., Prinz, M., Kalinke, U. and Langmann, T. (2016). Interferon-beta signaling in retinal mononuclear phagocytes attenuates pathological neovascularization. EMBO Molecular Medicine 8, 670678.CrossRefGoogle ScholarPubMed
Maenz, M., Schluter, D., Liesenfeld, O., Schares, G., Gross, U. and Pleyer, U. (2014). Ocular toxoplasmosis past, present and new aspects of an old disease. Progress in Retinal and Eye Research 39, 77106.CrossRefGoogle ScholarPubMed
Nagineni, C. N., Pardhasaradhi, K., Martins, M. C., Detrick, B. and Hooks, J. J. (1996). Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infection and Immunity 64, 41884196.CrossRefGoogle ScholarPubMed
Orellana, M. A., Suzuki, Y., Araujo, F. and Remington, J. S. (1991). Role of beta interferon in resistance to Toxoplasma gondii infection. Infection and Immunity 59, 32873290.CrossRefGoogle ScholarPubMed
Panjwani, N. (2014). Role of galectins in re-epithelialization of wounds. Annals of Translational Medicine 2, 89.Google ScholarPubMed
Rochet, É., Brunet, J., Sabou, M., Marcellin, L., Bourcier, T., Candolfi, E. and Pfaff, A. W. (2015). Interleukin-6-driven inflammatory response induces retinal pathology in a model of ocular toxoplasmosis reactivation. Infection and Immunity 83 , 21092117.CrossRefGoogle Scholar
Sadler, A. J. and Williams, B. R. (2008). Interferon-inducible antiviral effectors. Nature Reviews. Immunology 8, 559568.CrossRefGoogle ScholarPubMed
Sampson, J. F., Hasegawa, E., Mulki, L., Suryawanshi, A., Jiang, S., Chen, W. S., Rabinovich, G. A., Connor, K. M. and Panjwani, N. (2015). Galectin-8 ameliorates murine autoimmune ocular pathology and promotes a regulatory T cell response. PLoS ONE 10, e0130772.CrossRefGoogle ScholarPubMed
Sampson, J. F., Suryawanshi, A., Chen, W.-S., Rabinovich, G. A. and Panjwani, N. (2016). Galectin-8 promotes regulatory T-cell differentiation by modulating IL-2 and TGFβ signaling. Immunology and Cell Biology 94, 213219.CrossRefGoogle ScholarPubMed
Sehrawat, S., Suryawanshi, A., Hirashima, M. and Rouse, B. T. (2009). Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. Journal of Immunology 182, 31913201.CrossRefGoogle ScholarPubMed
Sehrawat, S., Reddy, P. B., Rajasagi, N., Suryawanshi, A., Hirashima, M. and Rouse, B. T. (2010). Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. PLoS Pathogens 6, e1000882.CrossRefGoogle ScholarPubMed
Sunil, V. R., Francis, M., Vayas, K. N., Cervelli, J. A., Choi, H., Laskin, J. D. and Laskin, D. L. (2015). Regulation of ozone-induced lung inflammation and injury by the beta-galactoside-binding lectin galectin-3. Toxicology and Applied Pharmacology 284, 236245.CrossRefGoogle ScholarPubMed
Suryawanshi, A., Cao, Z., Thitiprasert, T., Zaidi, T. S. and Panjwani, N. (2013). Galectin-1-mediated suppression of Pseudomonas aeruginosa–induced corneal immunopathology. The Journal of Immunology 190, 63976409.CrossRefGoogle ScholarPubMed
Suzuki, Y., Orellana, M. A., Schreiber, R. D. and Remington, J. S. (1988). Interferon-gamma: the major mediator of resistance against Toxoplasma gondii . Science 240, 516518.CrossRefGoogle ScholarPubMed
Suzuki, Y., Yang, Q. and Remington, J. S. (1995). Genetic resistance against acute toxoplasmosis depends on the strain of Toxoplasma gondii . Journal of Parasitology 81, 10321034.CrossRefGoogle ScholarPubMed
Vasta, G. R. (2009). Roles of galectins in infection. Nature Reviews Microbiology 7, 424438.CrossRefGoogle ScholarPubMed
Viguier, M., Advedissian, T., Delacour, D., Poirier, F. and Deshayes, F. (2014). Galectins in epithelial functions. Tissue Barriers 2, e29103.CrossRefGoogle ScholarPubMed
Wu, C., Thalhamer, T., Franca, R. F., Xiao, S., Wang, C., Hotta, C., Zhu, C., Hirashima, M., Anderson, A. C. and Kuchroo, V. K. (2014). Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. Immunity 41, 270282.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Primer sequences of mouse target cytokines and housekeeping genes used for quantitative real-time polymerase chain reaction (qRT–PCR) assays

Figure 1

Fig. 1. Histological changes (A) and the mRNA expressions of SAG1 (B) in the eyes of T. gondii-infected B6 and BALB/c mice at 8 dpi. Naive mice, no histological alterations were observed; B6 mice-infected with T. gondii at 8 dpi showed severe damage in the eye; BALB/c mice showed moderate damage in the eye. Original magnification for eyes × 40, H&E stain. The mRNA expressions of SAG1 in the eye tissues of T. gondii-infected mice were measured by using qRT–PCR. Values are means from triplicate measurements, and data are presented as means ± s.d. The statistical analysis was performed by independent-sample t-test; ***P < 0·001, T. gondii-infected B6 mice vs T. gondii-infected BALB/c mice. There were four mice per group, and data are representative of those from two experiments.

Figure 2

Fig. 2. The mRNA expressions of Gal-1, -3, -8 and -9 (A) and the receptors for Gal-9 (Tim-3, CD137, CD44 and PDI) (B) in the eyes and CLNs of T. gondii-infected mice at 8 dpi by using qRT–PCR. Values are means from triplicate measurements, and data are presented as means ± s.d. The statistical analysis was performed by independent-sample t-test; * P < 0·05, **P < 0·01, ***P < 0·001 vs control group; #P < 0·05, ###P < 0·001, T. gondii-infected B6 mice vs T. gondii-infected BALB/c mice. There were four mice per group, and data are the representative of those from two experiments.

Figure 3

Fig. 3. The mRNA expressions of IFN-α, IFN-β, IFN-γ, IL-6 and IL-10 in the eyes and CLNs of T. gondii-infected mice at 8 dpi by using qRT–PCR. (A) IFN-α, IFN-β and IFN-γ; (B) IL-6 and IL-10. Values are means from triplicate measurements, and data are presented as means ± s.d. The statistical analysis was performed by independent-sample t-test; *P < 0·05, **P < 0·01, ***P < 0·001 vs control group; #P < 0·05, ###P < 0·001, T. gondii-infected B6 mice vs T. gondii-infected BALB/c mice. There were four mice per group, and data are representative of those from two experiments.

Figure 4

Fig. 4. Histological changes in the eyes (A) and SAG1 mRNA expressions in the eye and CLN tissues (B) of T. gondii-infected BALB/c mice with or without α-lactose treatment. Moderate histopathological changes were observed in the eyes of T. gondii-infected BALB/c mice with or without α-lactose treatment at 8 dpi. Tachyzoites or pseudocysts were indicated with arrows; their enlarged images were shown in small windows. Original magnification for eyes tissues × 1000. H&E stain. The SAG1 mRNA expressions in the eyes and CLNs were measured by using qRT–PCR. Values are means from triplicate measurements, and data are presented as means ± s.d. The statistical analysis was performed by independent-sample t-test. There were four mice per group, and data are representative of those from two experiments.

Figure 5

Fig. 5. The mRNA expressions of IFN-α, IFN-β, IFN-γ, IL-6 and IL-10 in the eyes and CLNs of T. gondii-infected BALB/c mice with or without α-lactose treatment at 8 dpi by using qRT–PCR. (A) IFN-α, IFN-β and IFN-γ; (B) IL-6 and IL-10. Values are means from triplicate measurements, and data are presented as means ± s.d. The statistical analysis was performed by one-way ANOVA with LSD's post hoc test; *P < 0·05, ***P < 0·001 vs control group, #P < 0·05, ##P < 0·01, ###P < 0·001 vs α-lactose-control group. There were four mice per group, and data are representative of those from two experiments.